REVIEW The Year in Cardiology The Year in Cardiology 2012: focus on cardiovascular

Current data suggest that advances in cardiovascular (CV) treatment have resulted in significant reduction in CV mortality but also in pro-longation of life with disability. Focus on CV prevention is likely to reverse this unfavourable trend. In this review we provide information on the new European guidelines on CV prevention and discuss biomarkers and vascular imaging techniques which can assist in refining CV risk prediction. Finally, we provide new information on lifestyle and pharmacological advances which are likely to result in significant CV risk reduction